Crossmark

Safranal ameliorates atherosclerosis progression partly via repressing PI3K/Akt and NF-κB signaling pathways in ApoE (−/−) mice

Published Online: 2025-05-14

Authors

Geng, Yining

Song, Manping

Huang, Bing

Lin, Ru

Wu, Shiwen

Lin, An
License Information

Text and Data Mining valid from 2025-05-14

Version of Record valid from 2025-05-14
More Information

Article History

Received: 1 January 2025

Accepted: 3 May 2025

First Online: 14 May 2025

Declarations

:

: The author claims that there is no conflict of interest.

Document is current